Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
Frontiers | The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
Pharmaceuticals | Free Full-Text | In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist
Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension
Frontiers | The Role of the Kappa Opioid System in Comorbid Pain and Psychiatric Disorders: Function and Implications
Novel Dual-Target μ-Opioid Receptor and Dopamine D3 Receptor Ligands as Potential Nonaddictive Pharmacotherapeutics for Pain Management | Journal of Medicinal Chemistry
I'll Be Back”: The Resurrection of Dezocine | ACS Medicinal Chemistry Letters
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
Frontiers | The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
Kappa Opioid Receptor Activation Potentiates the Cocaine-Induced Increase in Evoked Dopamine Release Recorded In Vivo in the Mouse Nucleus Accumbens | Neuropsychopharmacology
Dynorphin-kappa opioid receptor activity in the central amygdala modulates binge-like alcohol drinking in mice | Neuropsychopharmacology
Prefrontal Cortical Kappa-Opioid Receptor Modulation of Local Neurotransmission and Conditioned Place Aversion | Neuropsychopharmacology
Frontiers | The Signaling and Pharmacology of the Dopamine D1 Receptor
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Dynorphin Controls the Gain of an Amygdalar Anxiety Circuit - ScienceDirect
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
![Standard Opioid Agonists Activate Heteromeric Opioid Receptors: Evidence for Morphine and [d-Ala2-MePhe4-Glyol5]Enkephalin as Selective μ−δ Agonists | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/cn9000236/asset/images/medium/cn-2009-000236_0007.gif "Standard Opioid Agonists Activate Heteromeric Opioid Receptors: Evidence for Morphine and [d-Ala2-MePhe4-Glyol5]Enkephalin as Selective μ−δ Agonists | ACS Chemical Neuroscience")
Standard Opioid Agonists Activate Heteromeric Opioid Receptors: Evidence for Morphine and [d-Ala2-MePhe4-Glyol5]Enkephalin as Selective μ−δ Agonists | ACS Chemical Neuroscience
Direct Selection of DNA-Encoded Libraries for Biased Agonists of GPCRs on Live Cells | JACS Au
Nanobody-enabled monitoring of kappa opioid receptor states | Nature Communications
Opioid antagonists are associated with a reduction in the symptoms of schizophrenia: a meta-analysis of controlled trials | Neuropsychopharmacology
κ-opioid receptor - Wikipedia
Kappa opioid receptor activation increases thermogenic energy expenditure which drives increased feeding - ScienceDirect
Cells | Free Full-Text | Levodopa-Induced Dyskinesia in Parkinson’s Disease: Pathogenesis and Emerging Treatment Strategies
